Friday, March 29, 2024 11:03:07 AM
I suspect you see the glass 1/2 empty while I see the glass 1/2 full - and getting fuller all the time with iBio's success - eh JOEY...?
I assure you - iBio exciting times are ahead pal...!
but unfortunately and sad to say for some novice and noob by-stander and non-investing investors, they missed "loading zone" boat - when others were "buy-buy-buying" and averaging down on their 'mother load'
which is now up substantially - and in positive territory - how do you like dem apples...?
unfortunately, I guess its more important for some to waste time posting how to use fake IP's, burner phones and multiple fake email addresses:
but here, let me help you with a lil "Math 101" with this below formula:
VWAP x VOLUME = TRADE VAL
so what this means is the following 3/4-Mil. $$$ sum is the total "dollas" that traded hands in 3 days time - in simplified terms for you, of course:
$221,546,817.90
$500,040,412.67
$854,201.98
______________
$722,441,532.55
now can you calculate what the "float churn" was for the 3 day running-spree which netted a 4-bagger for us iBio's SH's...?
and here is yet another simplified chart for your easy reading eyes to feast upon:
that's one hell of an amount of incoming dollas, aka money - which primarily states iBio has something going on - eh JOEY - or is it MiamiMark - oye veh...!
and I would also suspect it has something to do with clean PP funding, convertible lock-up, high strike price agreement, as well as...
RubrYc's IA Platform, substantial IP test results thus far, and the new biopharma collaboration in Obesity IP development, amount other milestone deliverables...
next time we'll discuss what non-milestone deliverables are and how investing in a twice failed Stanford U. "Financial Engineer" CEO hack
not once but twice over - will lead to loosing all your investment dollas
iBio's Can-O-Whoop Arse for yhee:
gots to go sporto, the Easter Bunny is a-knockin - cheers brah...!
MOO bad brains
Recent IBIO News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/13/2024 08:32:43 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/13/2024 08:30:55 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/13/2024 08:14:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/13/2024 08:08:29 PM
- iBio Reports Fiscal Third Quarter 2024 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 05/13/2024 08:05:00 PM
- iBio and AstralBio Announce Transformative AI drug discovery Collaboration to Rapidly Develop Novel Antibodies for Obesity and Cardiometabolic Diseases • GlobeNewswire Inc. • 03/27/2024 11:00:00 AM
- iBio Announces $15.0 Million Private Placement • GlobeNewswire Inc. • 03/26/2024 11:35:11 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/26/2024 12:59:30 PM
- iBio Announces Sale of Preclinical PD-1 Agonist Antibody Program to Otsuka • GlobeNewswire Inc. • 02/26/2024 12:45:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/21/2024 09:55:17 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/19/2024 09:36:09 PM
- iBio Announces Participation in 23rd Annual PepTalk Conference • GlobeNewswire Inc. • 01/16/2024 01:15:00 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 01/10/2024 06:24:39 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/08/2024 09:30:59 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 01/04/2024 01:00:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/26/2023 12:44:38 PM
- iBio Amends and Extends Maturity of Credit Agreement • GlobeNewswire Inc. • 12/26/2023 12:15:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/08/2023 09:17:13 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/06/2023 02:13:08 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 12/06/2023 01:59:51 PM
- iBio, Inc. Announces Pricing of $4.5 Million Public Offering • GlobeNewswire Inc. • 12/05/2023 01:00:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 12/05/2023 05:15:18 AM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 11/30/2023 01:55:22 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/28/2023 01:36:43 PM
- iBio Announces Reverse Stock Split • GlobeNewswire Inc. • 11/27/2023 10:20:00 PM
FEATURED Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • May 17, 2024 11:00 AM
VPR Brands (VPRB) Reports First Quarter 2024 Financial Results • VPRB • May 17, 2024 8:04 AM
ILUS Provides a First Quarter Filing Update • ILUS • May 16, 2024 11:26 AM
Cannabix Technologies and Omega Laboratories Inc. enter Strategic Partnership to Commercialize Marijuana Breathalyzer Technology • BLO • May 16, 2024 8:13 AM
Avant Technologies to Revolutionize Data Center Management with Proprietary AI Software Platform • AVAI • May 16, 2024 8:00 AM
HealthLynked Corp Announces First Quarter 2024 Results: Achieves 8% Revenue Growth Over Last Quarter • HLYK • May 16, 2024 8:00 AM